Gary Yang

1.7k total citations
69 papers, 1.1k citations indexed

About

Gary Yang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Gary Yang has authored 69 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 35 papers in Surgery and 23 papers in Oncology. Recurrent topics in Gary Yang's work include Esophageal Cancer Research and Treatment (19 papers), Gastric Cancer Management and Outcomes (19 papers) and Advanced Radiotherapy Techniques (14 papers). Gary Yang is often cited by papers focused on Esophageal Cancer Research and Treatment (19 papers), Gastric Cancer Management and Outcomes (19 papers) and Advanced Radiotherapy Techniques (14 papers). Gary Yang collaborates with scholars based in United States, Australia and Canada. Gary Yang's co-authors include Marwan Fakih, Milind Javle, Jerry D. Slater, Hector Nava, Chukwumere Nwogu, Renuka Iyer, John R. Subjeck, Sikander Ailawadhi, Shane Hopkins and Timothy Wagner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Gary Yang

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Yang United States 21 560 476 344 164 157 69 1.1k
Punita Lal India 21 278 0.5× 364 0.8× 374 1.1× 241 1.5× 93 0.6× 85 1.1k
Jannet C. Beukema Netherlands 21 914 1.6× 1.2k 2.4× 584 1.7× 118 0.7× 165 1.1× 46 1.8k
Yaping Xu China 19 495 0.9× 233 0.5× 411 1.2× 317 1.9× 51 0.3× 63 1.1k
Hubert de Crémoux France 19 806 1.4× 106 0.2× 410 1.2× 168 1.0× 115 0.7× 48 1.2k
Lars R. Holsti Finland 24 695 1.2× 280 0.6× 560 1.6× 170 1.0× 147 0.9× 72 1.6k
Sven Wenske United States 21 684 1.2× 283 0.6× 172 0.5× 188 1.1× 68 0.4× 41 1.2k
Wim P.J. Witjes Netherlands 29 1.4k 2.5× 982 2.1× 340 1.0× 236 1.4× 35 0.2× 92 2.8k
Edwin Boelke Germany 13 171 0.3× 186 0.4× 284 0.8× 94 0.6× 43 0.3× 39 694
Daher C. Chade United States 21 645 1.2× 691 1.5× 132 0.4× 189 1.2× 89 0.6× 41 1.3k
Cheryl Saenz United States 22 114 0.2× 336 0.7× 448 1.3× 412 2.5× 104 0.7× 59 1.8k

Countries citing papers authored by Gary Yang

Since Specialization
Citations

This map shows the geographic impact of Gary Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Yang more than expected).

Fields of papers citing papers by Gary Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Yang. The network helps show where Gary Yang may publish in the future.

Co-authorship network of co-authors of Gary Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Yang. A scholar is included among the top collaborators of Gary Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Yang. Gary Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Edward, et al.. (2023). Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy. Journal of Gastrointestinal Oncology. 14(3). 1613–1625. 2 indexed citations
2.
Slater, J., et al.. (2023). Image-Guided Proton Therapy: A Comprehensive Review. Cancers. 15(9). 2555–2555. 19 indexed citations
3.
Sharma, Navesh, S. Cheenu Kappadath, Michael D. Chuong, et al.. (2022). The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors. Brachytherapy. 21(5). 569–591. 7 indexed citations
4.
Hsueh, Chung-Tsen, Annie Park, Naveenraj L. Solomon, et al.. (2022). A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer. Journal of Gastrointestinal Oncology. 13(4). 1989–1996. 3 indexed citations
5.
Yeo, I, Ian Gordon, R. Schulte, et al.. (2015). Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer. Radiation Oncology. 10(1). 213–213. 11 indexed citations
6.
Guo, Chunqing, Huanfa Yi, Xiaofei Yu, et al.. (2012). In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer. Molecular Cancer Therapeutics. 11(11). 2331–2341. 28 indexed citations
7.
Slater, Jerry D., et al.. (2012). Stereotactic body proton therapy for liver metastases. Translational Cancer Research. 1(4). 271–275. 2 indexed citations
8.
Slater, Jerry D., et al.. (2012). Proton therapy for gastrointestinal cancers. Translational Cancer Research. 1(3). 150–158. 10 indexed citations
9.
Slater, Jerry D., et al.. (2011). Proton therapy for esophageal cancer. Thoracic Cancer. 3(1). 91–93. 4 indexed citations
10.
Yap, Johnny, H Malhotra, & Gary Yang. (2010). Intensity modulated radiation therapy in the treatment of esophageal cancer. Thoracic Cancer. 1(2). 62–69. 7 indexed citations
11.
Yendamuri, Sai, Terry Mashtare, Nikhil I. Khushalani, et al.. (2010). Does Circular Stapled Esophagogastric Anastomotic Size Affect the Incidence of Postoperative Strictures?. Journal of Surgical Research. 165(1). 1–4. 16 indexed citations
12.
Javle, Milind, Gary Yang, Gregory E. Wilding, et al.. (2009). Capecitabine, Oxaliplatin and Radiotherapy: A Phase IB Neoadjuvant Study for Esophageal Cancer with Gene Expression Analysis. Cancer Investigation. 27(2). 193–200. 14 indexed citations
13.
Fakih, Marwan, Gary Yang, Lakshmi Pendyala, et al.. (2008). Phase II Study of Weekly Intravenous Oxaliplatin Combined With Oral Daily Capecitabine and Radiotherapy With Biologic Correlates in Neoadjuvant Treatment of Rectal Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 72(3). 650–657. 26 indexed citations
14.
Javle, Milind, Renuka Iyer, Gary Yang, et al.. (2008). Pilot Study of Gefitinib, Oxaliplatin, and Radiotherapy for Esophageal Adenocarcinoma. American Journal of Clinical Oncology. 31(4). 329–334. 29 indexed citations
15.
Durrani, Farukh A., Shousong Cao, Young‐Mee Park, et al.. (2007). Synergistic effect of selenium compounds with radiation therapy in human A549 lung xenografts. Cancer Research. 67. 750–750. 2 indexed citations
16.
Puthillath, Ajithkumar, Kelli Bullard Dunn, Ashwani Rajput, et al.. (2007). Safety and Efficacy of First-Line Chemotherapy in Unresected Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 6(10). 710–715. 7 indexed citations
17.
Yang, Gary, et al.. (2006). Misrepresentation of Publications Among Radiation Oncology Residency Applicants. Journal of the American College of Radiology. 3(4). 259–264. 36 indexed citations
18.
Park, Eun‐Mi, Nithya Ramnath, Gary Yang, et al.. (2006). High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis. Free Radical Biology and Medicine. 42(2). 280–287. 45 indexed citations
19.
Nallapareddy, Sujatha, Gregory E. Wilding, Gary Yang, Renuka Iyer, & Milind Javle. (2005). Chemoradiation is a tolerable therapy for older adults with esophageal cancer.. PubMed. 25(4). 3055–60. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Punita Lal Breakdown of academic impact, for papers by Jannet C. Beukema Breakdown of academic impact, for papers by Yaping Xu Breakdown of academic impact, for papers by Hubert de Crémoux Breakdown of academic impact, for papers by Lars R. Holsti Breakdown of academic impact, for papers by Sven Wenske Breakdown of academic impact, for papers by Wim P.J. Witjes Breakdown of academic impact, for papers by Edwin Boelke Breakdown of academic impact, for papers by Daher C. Chade Breakdown of academic impact, for papers by Cheryl Saenz
Rankless by CCL
2026